Ronit Fainaro-Satchi

Tel Aviv, TA 69978, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 110 publications

Double-coated PLGA nanoparticles with hierarchical surface architecture for CD44-targeted siRNA delivery.

Double-coated PLGA nanoparticles with hierarchical surface architecture for CD44-targeted siRNA delivery.

Journal: Drug delivery and translational research

Published: February 16, 2026

Harnessing the power of microbiome, nanotechnology, and immunity against cancer.

Harnessing the power of microbiome, nanotechnology, and immunity against cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 22, 2025

Harnessing Next-Generation 3D Cancer Models to Elucidate Tumor-Microbiome Crosstalk.

Harnessing Next-Generation 3D Cancer Models to Elucidate Tumor-Microbiome Crosstalk.

Journal: Advanced healthcare materials

Published: June 26, 2025

A novel Frizzled 7 antibody disrupts the Wnt pathway and inhibits Wilms tumor growth.

A novel Frizzled 7 antibody disrupts the Wnt pathway and inhibits Wilms tumor growth.

Journal: Frontiers in bioengineering and biotechnology

Published: June 04, 2025

Patient-Derived 3D-Bioprinted Models of Pancreatic Cancer: Toward Personalized Therapy and Overcoming Tumor Microenvironment Challenges.

Patient-Derived 3D-Bioprinted Models of Pancreatic Cancer: Toward Personalized Therapy and Overcoming Tumor Microenvironment Challenges.

Journal: Advanced drug delivery reviews

Published: April 20, 2025

Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.

Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: February 21, 2025

IRS2 as a driver of brain metastasis in colorectal cancer: A potential target for novel therapeutic strategies.

IRS2 as a driver of brain metastasis in colorectal cancer: A potential target for novel therapeutic strategies.

Journal: Neuro-oncology

Published: January 31, 2025

Thymidine Phosphodiester Chemiluminescent Probe for Sensitive and Selective Detection of Ectonucleotide Pyrophosphatase 1.

Thymidine Phosphodiester Chemiluminescent Probe for Sensitive and Selective Detection of Ectonucleotide Pyrophosphatase 1.

Journal: Bioconjugate chemistry

Published: January 09, 2025

Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy.

Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 17, 2024

Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers.

Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers.

Journal: Science advances

Published: December 13, 2024

Cancer Organoids as reliable disease models to drive clinical development of novel therapies.

Cancer Organoids as reliable disease models to drive clinical development of novel therapies.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 13, 2024

Biocompatible Flash Chemiluminescent Assay Enabled by Sterically Hindered Spiro-Strained-Oxetanyl-1,2-Dioxetane.

Biocompatible Flash Chemiluminescent Assay Enabled by Sterically Hindered Spiro-Strained-Oxetanyl-1,2-Dioxetane.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: August 08, 2024

Showing 1-12 of 110

Last Updated: 09/26/2026